Holen Sie sich die Stockscreener-App
2.21
0.45%
0.010
Schlusskurs vom Vortag:
$2.20
Offen:
$2.24
24-Stunden-Volumen:
9,022
Relative Volume:
0.12
Marktkapitalisierung:
$3.92M
Einnahmen:
$770.00K
Nettoeinkommen (Verlust:
$-38.84M
KGV:
-0.1556
EPS:
-14.2049
Netto-Cashflow:
$-43.02M
1W Leistung:
+11.06%
1M Leistung:
-37.92%
6M Leistung:
-73.66%
1J Leistung:
-76.27%
1-Tages-Spanne:
$2.20
$2.31
1-Wochen-Bereich:
$1.94
$2.58
52-Wochen-Spanne:
$1.63
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Firmenname
Lyra Therapeutics Inc
Sektor
Branche
Telefon
617-373-4600
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Vergleichen Sie LYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
2.21 | 3.90M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.70 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.16 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
823.61 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
363.15 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.47 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Fortgesetzt | BTIG Research | Buy |
| 2023-08-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Eingeleitet | BTIG Research | Buy |
| 2020-05-26 | Eingeleitet | BofA/Merrill | Buy |
| 2020-05-26 | Eingeleitet | Jefferies | Buy |
| 2020-05-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten
How Lyra Therapeutics Inc. stock reacts to Fed rate cutsFederal Reserve Announcements & Fast Growing Portfolio Trading - bollywoodhelpline.com
How cyclical is Lyra Therapeutics Inc.’s revenue streamPortfolio Performance Summary & Accurate Intraday Trading Signals - bollywoodhelpline.com
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
Aug Spikes: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Bearish Setup: Will Cheniere Energy Inc stock hit new highs in YEARWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace
How much upside does Lyra Therapeutics Inc. have2025 Valuation Update & Weekly Sector Rotation Insights - bollywoodhelpline.com
Will Lyra Therapeutics Inc be affected by tariffsJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
EV Market: Will Lyra Therapeutics Inc stock maintain momentum in 2025Analyst Downgrade & Weekly Return Optimization Plans - Bộ Nội Vụ
Lyra Therapeutics suspends further development of LYR-210 - Yahoo Finance
Lyra Therapeutics halts development of lead CRS treatment By Investing.com - Investing.com Nigeria
Mass. biotech company lays off entire workforce as cash dwindles - nbcboston.com
Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Watertown biotech suspends drug development and eliminates workforce as cash dwindles - The Business Journals
LYRA Plunges 55% After Company Halts Lead Program And Begins Strategic Review - Nasdaq
Why Is Lyra Therapeutics Stock (LYRA) Down Today? - TipRanks
Lyra Therapeutics plunges after halting development of lead nasal drug - TradingView — Track All Markets
Lyra Therapeutics Inc terminates CEO Maria Palasis and CFO Jason CavalierSEC filing - marketscreener.com
Lyra Therapeutics halts development of lead CRS treatment - Investing.com
Lyra Therapeutics Provides Corporate Update - The Manila Times
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Is Lyra Therapeutics Inc. stock attractive after correctionJuly 2025 Fed Impact & Verified Entry Point Signals - Улправда
Can Lyra Therapeutics Inc. stock attract ESG capital inflowsWeekly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
Published on: 2026-01-08 23:57:46 - Улправда
What momentum indicators show for Lyra Therapeutics Inc. stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - ulpravda.ru
ulpravda> 2026> How CHCT stock benefits from tech adoptionRecession Risk & Trade Opportunity Analysis Reports - ulpravda.ru
Is Lyra Therapeutics Inc. stock attractive for income investors2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Can Lyra Therapeutics Inc. stock sustain revenue growthSwing Trading Ideas & Our Picks = Your Future Gains - Улправда
Breakouts Watch: How supply chain issues affect Lyra Therapeutics Inc stockWeekly Investment Recap & Real-Time Stock Entry Alerts - Bộ Nội Vụ
Would You Accumulate or Wait on Hoac Foods India Limited (HOACFOODS)Earnings Miss Alerts & Small Investment Growth Tips - bollywoodhelpline.com
Will Lyra Therapeutics Inc. stock outperform value stocks2025 Performance Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Lyra Therapeutics (NASDAQ:LYRA) Trading Up 0.3% – Time to Buy? - Defense World
LYRA (Lyra Therapeutics) EV-to-OCF : -0.46 (As of Dec. 22, 2025) - GuruFocus
Can Lyra Therapeutics Inc. stock surprise with earnings upside2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - Bölüm Sonu Canavarı
Is Lyra Therapeutics Inc. stock a buy for dividend growthJuly 2025 Movers & Low Risk High Win Rate Stock Picks - Улправда
Lyra Therapeutics Earnings Notes - Trefis
Take Profit: Will Lyra Therapeutics Inc. stock outperform value stocksPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Why Lyra Therapeutics Inc. stock remains on buy listsJuly 2025 WrapUp & Weekly High Momentum Picks - Улправда
Insmed drops as it abandons brensocatib in rhinosinusitis - Seeking Alpha
Lyra Therapeutics Stock Rockets 56% With 6-Day Winning Streak - Trefis
Will Lyra Therapeutics Inc. stock pay special dividends2025 Trade Ideas & High Conviction Investment Ideas - Newser
Lyra Therapeutics (LYRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Lyra Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Will Lyra Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-11-27 15:46:05 - moha.gov.vn
PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus
Will Product Innovation Drive Hisar Spinning Mills Limited Stock in YEARRisk Management Strategies & Free Extraordinary Earning Power - earlytimes.in
Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com
Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lyra Therapeutics Inc-Aktie (LYRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Palasis Maria | President & CEO |
Jan 06 '26 |
Sale |
3.36 |
1,702 |
5,726 |
1,096,733 |
3.36%
2.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):